Edward Wholihan serves as Executive at Allena Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Edward Wholihan has executed 10 insider transactions totaling $93.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 2, 2026 involved receiving (via award) 2,581 shares valued at $15.0K.
Edward Wholihan currently holds 44,269 shares of Allena Pharmaceuticals, Inc. (ALNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Edward Wholihan has been a net seller of ALNA stock. They have purchased $0 and sold $93.2K worth of shares.
Edward Wholihan's most recent insider trade was on Jan 2, 2026, when they sold 2,581 shares at $5.81 per share.
Get notified when new Form 4 filings are submitted
| $3.83 |
| Discretionary |
| Jul 2, 2025 | KRMD | $15.0K | Award | 4,189 | $3.58 | Discretionary |
| Jul 11, 2024 | KRMD | $15.0K | Award | 5,545 | $2.71 | Discretionary |
| Mar 31, 2024 | KRMD | $15.0K | Award | 6,329 | $2.37 | Discretionary |
| Dec 31, 2023 | KRMD | $15.0K | Award | 6,329 | $2.37 | Discretionary |
| Sep 30, 2023 | KRMD | $326 | Award | 119 | $2.74 | Discretionary |
| Dec 17, 2020 | ALNA | $0 | Option Exercise | 164,822 | $N/A | Discretionary |
| Dec 17, 2020 | ALNA | $93.2K | Sale | 68,550 | $1.36 | Discretionary |
| May 9, 2018 | ALNA | $39.8K | Option Exercise | 25,000 | $1.59 | Discretionary |